SCHEMBL825500

SCHEMBL825500

O=C(O)N[C@@H]1CC=CCC1

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
KDM4E B2RXH2 2/20 0.38
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
TSHR P16473 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ALOX15 P16050 2/20 0.35
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35
ESR2 Q92731 1/20 0.35
HSD17B10 Q99714 1/20 0.35
AKR1C3 P42330 1/20 0.31
RAB9A P51151 1/20 0.31
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL468211 1.00 ALDH1A1 (0.38) ALDH1A1KDM4ELMNATP53TSHR
SCHEMBL7369842 1.00 ALDH1A1 (0.38) ALDH1A1KDM4ELMNATP53TSHR
Carbamic Acid SCHEMBL21617652 0.94 ALDH1A1 (0.35) ALDH1A1KDM4ELMNATP53TSHR
SCHEMBL460381 0.89 ALDH1A1 (0.37) ALDH1A1KDM4ESMN1; SMN2MEN1MAPT
SCHEMBL1960138 0.84
SCHEMBL14789368 0.81 ATM (0.42) ALDH1A1KDM4ELMNATP53TSHR
SCHEMBL11161552 0.81 ATM (0.42) ALDH1A1KDM4ELMNATP53TSHR
SCHEMBL27976966 0.81 ALDH1A1 (0.34) ALDH1A1KDM4ELMNATP53TSHR
SCHEMBL28110628 0.78 MAPT (0.47) ALDH1A1KDM4ELMNATP53TSHR
SCHEMBL23169131 0.76 SMN1; SMN2 (0.63) ALDH1A1KDM4ESMN1; SMN2MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2576505-A1 PROCESS FOR THE PREPARATION OF PLEUROMUTILINS Nabriva Therapeutics AG (AT) 2013-04-10 EP disclosed
WO-2011146954-A1 PROCESS FOR THE PREPARATION OF PLEUROMUTILINS NABRIVA THERAPEUTICS AG (AT) 2011-12-01 WO disclosed